Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (41-50 of 328) with videos related to

Pageof 33
Sort By:
Clinical Immunology (Orlando, Fla.)|December 31, 2003
In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disordersPriscilla Biswas, Barbara Mantelli, Hamid Hasson, et al.
AIDS (London, England)|August 14, 2013
Highlights on HIV eradication in 2013Antonella d'Arminio Monforte, Valentina Svicher, Silvia Nozza, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 31, 2002
Neurobrucellosis with spinal cord abscess of the dorsal tract: a case reportRoberto Novati, Maria Grazia Viganò, Anna de Bona, et al.
AIDS (London, England)|December 20, 2007
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivityAndrea Caumo, Monica Guffanti, Gianluca Perseghin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytesMarina Ferrarini, Fanny Delfanti, Monica Gianolini, et al.
Antiviral Therapy|February 2, 2012
Mortality of HIV-infected patients with or without cancer: comparison with the general population in ItalyLaura Galli, Vincenzo Spagnuolo, Stefania Salpietro, et al.
Journal of Medical Virology|December 26, 2003
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapyNicola Gianotti, Alessandro Soria, Laura Galli, et al.
Therapeutics and Clinical Risk Management|July 20, 2017
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patientsUmberto Restelli, Giuliano Rizzardini, Andrea Antinori, et al.
AIDS (London, England)|October 8, 2013
Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirineAlessia Carbone, Alba Bigoloni, Laura Galli, et al.
European Journal of Immunology|February 21, 2003
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infectionPriscilla Biswas, Marina Ferrarini, Barbara Mantelli, et al.
Pageof 33

Showing results (41-50 of 328) with videos related to

Sort By:
Pageof 33
Clinical Immunology (Orlando, Fla.)|December 31, 2003
In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disordersPriscilla Biswas, Barbara Mantelli, Hamid Hasson, et al.
AIDS (London, England)|August 14, 2013
Highlights on HIV eradication in 2013Antonella d'Arminio Monforte, Valentina Svicher, Silvia Nozza, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 31, 2002
Neurobrucellosis with spinal cord abscess of the dorsal tract: a case reportRoberto Novati, Maria Grazia Viganò, Anna de Bona, et al.
AIDS (London, England)|December 20, 2007
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivityAndrea Caumo, Monica Guffanti, Gianluca Perseghin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytesMarina Ferrarini, Fanny Delfanti, Monica Gianolini, et al.
Antiviral Therapy|February 2, 2012
Mortality of HIV-infected patients with or without cancer: comparison with the general population in ItalyLaura Galli, Vincenzo Spagnuolo, Stefania Salpietro, et al.
Journal of Medical Virology|December 26, 2003
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapyNicola Gianotti, Alessandro Soria, Laura Galli, et al.
Therapeutics and Clinical Risk Management|July 20, 2017
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patientsUmberto Restelli, Giuliano Rizzardini, Andrea Antinori, et al.
AIDS (London, England)|October 8, 2013
Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirineAlessia Carbone, Alba Bigoloni, Laura Galli, et al.
European Journal of Immunology|February 21, 2003
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infectionPriscilla Biswas, Marina Ferrarini, Barbara Mantelli, et al.
Pageof 33